Ocrelizumab
Ocrelizumab recommended for licencing by European Medicines Agency for relapsing remitting and early primary progressive MS
Ocrelizumab recommended for licencing by European Medicines Agency for relapsing remitting and early primary progressive MS
Fund for students with disabilities to be extended to part-time students
They say of men and doctors, we don’t go if it’s not bleeding, broken and still gets up. Trevis Gleason went to the doctor…
Over the coming months the MS Ireland Western Regional Office are hoping to run a 'Mindfulness Course' for people with MS. However, we would like to gauge the level of interest in such a course before we book a qualified facilitator.
Briefing Document and Position Paper on the need for an MS registry in Ireland
Global experts publish recommendations for overcoming challenges to improve clinical trials in progressive MS
Hearing loss, or impaired hearing, is an uncommon symptom of MS, Helen Farrell discusses the affect it has on her daily life.
© 2010 - 2024 Multiple Sclerosis Society of Ireland